U.S ANNOUNCES VISA CURBS FOR SOME FOREIGN NATIONALS IN SOUTH AFRICA. (PHOTO).

Image
 U.S announces visa curbs for some foreign nationals in South Africa Secretary of State Marco Rubio ‌said on Tuesday the U.S. government was announcing a new visa restriction ​policy targeting some foreign nationals ​in South Africa. The policy targets "foreign ⁠nationals who are responsible for, ​or complicit in, the enactment or ​implementation of laws or policies that enable uncompensated land seizures, race-based discrimination, and/or ​the incitement of imminent violence ​against members of minority ethnic or racial ‌groups ⁠in South Africa," Rubio said in a statement. "The South African government has not adequately addressed the ​previously laid ​out ⁠concerns," Rubio said, Reuters reported. Relations between Washington and Pretoria have ​soured since the start of ​Donald ⁠Trump's second term, with the U.S. president criticizing the country ⁠for ​its policies aimed at ​addressing racial inequality.

CHINESE COVID-19 VACCINE SHOWS PROMISING RESULTS.[PHOTO}.

Chinese COVID-19 vaccine shows promising results - CGTN
   We are all expecting a COVID-19 vaccine that could possibly end the pandemic that has killed more than 330,000 people.
Now the first vaccine candidate from China has finished its phase-1 trial on humans, and the results have been put online for everyone to examine.
The Lancet, a respected medical journal in the UK, published the results on Friday saying it is "safe" and "induces rapid immune response."
The research injected the potential vaccine into 108 volunteers.
They were divided into three groups, each taking a different dose of the vaccine.
The vaccine, classified as "recombinant adenovirus type-5 vectored" (Ad5-nCoV), acts as a natural infection and is especially good at teaching the immune system how to fight the virus.During the next 28 days, no serious reactions were found, meaning the vaccine seemed to be tolerable by humans.Also, antibodies against the SARS-CoV-2 started to surge two weeks after the injection and reached its peak on day 28.The vaccine "warrants further investigation," the paper on The Lancet concluded.A phase-2 clinical trial has started with 508 volunteers involved.The trial was conducted by a team led by Chen Wei, a biology professor from Academy of Military Medical Sciences and a member of the Chinese Academy of Engineering.There are other two vaccines allowed for human trials in China. They are ShaCoVacc and PiCoVacc.-CCTV.
Chinese COVID-19 vaccine shows promising results - CGTN

Comments

Popular posts from this blog

INNOSON GIVES OUT BRAND NEW IVM G5 AND SALARY FOR LIFE TO THE MAN WHO PROPHESIED ABOUT HIS VEHICLE MANUFACTURING IN 1979.(PHOTO).

MUSICIAN HARRY-SONG,REVEALS THE FACE OF THE FEMALE FAN WHO IS THREATENING TO KILL HIM.{PHOTOS}.

THE NEW OONI OF ILE-IFE,WILL NOT EAT THE HEART OF THE LATE OONI-PALACE CHIEFS.